The Google note-taking tool NotebookLM uses Gemini 3.0 for higher-quality sources and summaries, giving you quicker answers ...
Inebilizumab-cdon is approved for anti-acetylcholine receptor and anti-muscle specific tyrosine kinase antibody–positive generalized myasthenia gravis, based on MINT trial results. Inebilizumab gains ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback